2009
DOI: 10.1211/jpp.61.04.0002
|View full text |Cite
|
Sign up to set email alerts
|

Phycocyanin liposomes for topical anti-inflammatory activity: in-vitro in-vivo studies

Abstract: The results showed that C-PC can be successfully used as an anti-inflammatory drug and that liposomal encapsulation is effective in improving its anti-inflammatory activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
30
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 58 publications
(33 citation statements)
references
References 40 publications
1
30
0
Order By: Relevance
“…In addition, liposomes were highly biocompatible, as demonstrated by the in vitro studies that were carried out while using human keratinocytes. The ability of liposomes to improve the delivery of small and large molecules to the skin is well known [38,39]. Recently, they have been successfully proposed for the skin delivery of phytochemicals due to their high loading and carrier capabilities, as well as affinity with the skin [40].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, liposomes were highly biocompatible, as demonstrated by the in vitro studies that were carried out while using human keratinocytes. The ability of liposomes to improve the delivery of small and large molecules to the skin is well known [38,39]. Recently, they have been successfully proposed for the skin delivery of phytochemicals due to their high loading and carrier capabilities, as well as affinity with the skin [40].…”
Section: Discussionmentioning
confidence: 99%
“…C-phycocyanin (Cpc), a major type of phycocyanin of phycobilisome in spirulina, has been suggested to exhibit radical-scavenging property [1] to reduce inflammatory responses [2,3] and oxidative stress [1,4]. This phycobiliprotein also induces HeLa cell apoptosis [5,6] enhances wound healing [7], retards platelet aggregation [8,9] and acts as a photodynamic agent to eradicate cancer cells in vitro [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…An increase in topical bio-availability of dermatological gents has been reported for liposomes containing gel-forming polymers [61,64]. Although two decades have passed since liposomes were first postulated as drug carriers, there is only one marketed topical liposomal drug formulation, Pevaryl lipogel produced by Cilag AG (now Johnson and Johnson) which became available in Switzerland in 1988.…”
Section: Liposomesmentioning
confidence: 99%
“…Acyclovir is an antiviral used in treating viral infections of the skin and mucosa. Acyclovir is poorly absorbed across the skin due to its hydrophilic nature, and therefore not able to reach its target site in the basal epidermis, this results in reduced therapeutic efficacy [64,125]. Acyclovir is currently marketed as a cream formulation and licensed to be used topically for the treatment of herpes simplex virus (HSV), however due to its slow diffusion across the skin, it is recommended to be applied five times daily [64,126].…”
Section: Iontophoresismentioning
confidence: 99%